Oregon Health and Science UniversityPortland, OR
Disclosures:
3007 - Observed Survival for Esophageal Cancer Patients Receiving High-Dose (>50Gy) vs. Low-Dose (=45.0 Gy) Radiation in Tri-Modality Therapy and Differences in Dose to Thoracic Organs at Risk (OAR)
Tuesday, October 1, 202412:45 PM – 2:00 PM ET
3344 - Multi-Cancer Early Detection Utilizing Blood-Based Genomics: Single-Institution Case Series of Novel Cancer Screening
Tuesday, October 1, 20244:00 PM – 5:00 PM ET
